Applicare

Founded in 2021 by Dr. Mariem Abid, applicare.ai is a Montreal-based scientific company dedicated to developing prognostic digital biomarkers and applied artificial intelligence solutions for the healthcare sector. The company’s core mission is to augment human clinical expertise with AI, empowering healthcare professionals to anticipate clinical risks, monitor high-risk patients, and prevent life-threatening complications through actionable, data-driven insights.

At its foundation, applicare.ai specializes in analyzing complex, continuous physiological time-series data collected via device-agnostic, medical-grade sensors and the medical Internet of Things (IoT). By applying robust machine learning and deep learning algorithms, the company transforms raw vital signs into reliable predictive scores. 

A defining hallmark of applicare.ai’s technological approach is a strict commitment to Explainable AI (XAI). Understanding that clinical adoption of medical devices requires absolute transparency, the company implements advanced interpretability mechanisms to decode the traditional "black box" of machine learning. By directly correlating AI prediction scores to specific molecular and cellular biomarkers, applicare.ai ensures that clinicians receive a clear, clinically validated rationale alongside every diagnostic prediction.

Deeply rooted in the Quebec innovation ecosystem, applicare.ai has been validated through rigorous accelerator programs, including District 3, the Quebec Scientific Entrepreneurship Program (QcSE), and Défi Montréal, and was recognized as a top finalist in the 2022 Coopérathon. Furthermore, the company is actively invested in training the next generation of Canadian AI talent. Through its cross-sector collaborations, applicare.ai builds an essential bridge between the rigor of academic research and industrial innovation in healthcare.